Location History:
- Rockville, MD (US) (2016 - 2018)
- Boyds, MD (US) (2019 - 2021)
- Doha, QA (2021 - 2024)
Company Filing History:
13 out of 3,540 
2 out of 1,187 
2 out of 666 
Years Active: 2016-2025
Certainly! Here is an article about inventor Hadi M Yassine:
Title: Driving Innovation in Vaccine Development: The Inspiring Journey of Hadi M Yassine
Introduction:
In the heart of Doha, Qatar, inventor Hadi M Yassine stands as a beacon of innovation and excellence, inspiring the next generation of inventors worldwide. With a passion for pushing the boundaries of technology, Yassine's work in vaccine development has revolutionized the fight against influenza.
Latest Patents:
Yassine's latest patents showcase his groundbreaking work in developing vaccines that elicit broadly protective anti-influenza antibodies. One of his notable inventions includes "Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof," where nanoparticles display HA trimers from Group 2 influenza viruses on their surface, leading to advanced vaccine formulations.
Career Highlights:
Having accumulated a total of 9 patents, Yassine has cemented his legacy as a leading figure in the field of vaccine research. Throughout his career, he has made significant contributions to the United States of America, as Represented by the Secretary, Department of Health and Human Services, and The Scripps Research Institute.
Collaborations:
Yassine's collaborative spirit has further propelled his success, working alongside esteemed colleagues such as Masaru Kanekiyo and Jeffrey C Boyington. Together, they have paved the way for groundbreaking discoveries in vaccine technology.
Conclusion:
In conclusion, Hadi M Yassine's dedication to innovation and tireless pursuit of excellence have not only shaped the future of technology but have also inspired countless individuals to push the boundaries of what is possible. His impact on vaccine development resonates far and wide, leaving a lasting legacy for generations to come.